Tumors of female reproductive systemTumors of female reproductive systemОпухоли женской репродуктивной системы1994-40981999-8627Publishing House ABV Press18510.17650/1994-4098-2011-0-3-96-98GYNECOLOGY. TREATMENTГИНЕКОЛОГИЯ. ЛЕЧЕНИЕTreatment of patients with brain metastases from ovarian cancer: clinical observationЛечение больных с метастазами рака яичников в головном мозге: клиническое наблюдениеKarakhanV. B.КараханВ. Б.
Russian Federation
NaskhletashviliD. R.НасхлеташвилиД. Р.
Russian Federation
Nas-david@yandex.ruSevyanN. V.СевянН. В.
Russian Federation
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowРОНЦ им. Н.Н. Блохина РАМН, Москва140820113969818082014180820142011https://ojrs.abvpress.ru/ojrs/article/view/185

The capacity of drugs to penetrate across the blood-brain barrier (BBB) is primarily traditionally taken into account on choosing chemotherapy (CT) regimens for patients with brain metastatic involvement. P aclitaxel and carboplatin have a low ability to cross the BBB in its normal state. As of now, there is experimental and clinical evidence for BBB dysfunction in brain metastases. The described case serves as another evidence for the successful application of standard approaches to choosing CT regimens for patients with platinum-susceptible recurrent ovarian cancer when the disease recurs and progresses as brain metastatic involvement. The authors also show the effe ctive use of combination treatment: CT in combination with radiation treatments (stereotactic radiosurgery and conventional whole brain radiotherapy) with complete tumor regression being achieved in a patient with ovarian cancer and brain metastatic involvement.

brainmetastasesovarian cancerchemotherapyголовной мозгметастазырак яичниковхимиотерапия1. Ромаданов А.П., Зозуля Ю.А., Соснов Ю.Д. Метастатические опухоли головного мозга. Киев, 1973.Ромаданов А.П., Зозуля Ю.А., Соснов Ю.Д. Метастатические опухоли головного мозга. Киев, 1973.2. Barker G.H., Orledge J., Wiltshaw E. Involvement of the central nervous system inpatients with ovarian carcinoma. Br J Cancer 1981;88:690–4.Barker G.H., Orledge J., Wiltshaw E. Involvement of the central nervous system inpatients with ovarian carcinoma. Br J Cancer 1981;88:690–4.3. Cormio G., Maneo A., Parma G. et al. Central nervous system metastases inpatients with ovarian carcinoma. Ann Oncol 1995;6:571–4.Cormio G., Maneo A., Parma G. et al. Central nervous system metastases inpatients with ovarian carcinoma. Ann Oncol 1995;6:571–4.4. Li A.J., Karlan B.Y. Genetic factors in ovarian carcinoma. Curr Oncol Rep 2001;3:27–32.Li A.J., Karlan B.Y. Genetic factors in ovarian carcinoma. Curr Oncol Rep 2001;3:27–32.5. Bonnefoi H., A’Hern R.P., Fisher C. et al. Natural history of stage IV epithelial ovarian cancer. J Clin Oncol 1999; 17:767–75.Bonnefoi H., A’Hern R.P., Fisher C. et al. Natural history of stage IV epithelial ovarian cancer. J Clin Oncol 1999; 17:767–75.6. Mayer R.J., Berkowitz R.S., Griffiths C.T. Central nervous system involvement by ovarian carcinoma: A complication of prolonged survival with metastatic disease. Cancer 1978;41:776–83.Mayer R.J., Berkowitz R.S., Griffiths C.T. Central nervous system involvement by ovarian carcinoma: A complication of prolonged survival with metastatic disease. Cancer 1978;41:776–83.7. Patchell R.A., Tibbs P.A., Walsh J.W. A randomised trial in the surgery of treatment of single metastasis to the brain. N Engl J Med 1990;332:494–500.Patchell R.A., Tibbs P.A., Walsh J.W. A randomised trial in the surgery of treatment of single metastasis to the brain. N Engl J Med 1990;332:494–500.